Get started
Author

Louise Rethacker

NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment
2019 · Alexandra Frazao, Louise Rethacker, et al. · Frontiers in Immunology · 105
PDF
Innate lymphoid cells: NK and cytotoxic ILC3 subsets infiltrate metastatic breast cancer lymph nodes
2022 · Louise Rethacker, Maxime Boy, et al. · OncoImmunology · 22
PDF
BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis
2020 · Alexandra Frazao, Louise Rethacker, et al. · Journal for ImmunoTherapy of Cancer · 22
PDF
Specific Patterns of Blood ILCs in Metastatic Melanoma Patients and Their Modulations in Response to Immunotherapy
2021 · Louise Rethacker, Marie Roelens, et al. · Cancers · 20
PDF
CRISPR Screens Identify Key Regulators of NK Cell Cytotoxicity in Cancer Therapy
2024 · Louise Rethacker, Hugo Romero, et al. · The Journal of Immunology · 1
Two-dimensional dynamic evaluation of natural killer cell-mediated lysis of adherent target cells
2019 · Alexandra Frazao, Louise Rethacker, et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 1
PDF
1258P ULBP2 drives a non-canonical NK cell cytotoxicity in B-ALL: A novel mechanism associated with improved patient survival
2025 · S. Nicoletti, L. Rethacker, et al. · Annals of Oncology
Les cellules lymphocytaires innées dans l’immunosurveillance des tumeurs métastatiques
2021 · Louise Rethacker · theses.fr (ABES)
Challenges for NK cell-based therapies: What can we learn from lymph nodes?
2021 · Louise Rethacker, Nicolas Dulphy, et al. · Elsevier eBooks
Hépatite sévère induite par ipilimumab plus nivolumab traitée par photochimiothérapie extracorporelle : premier cas
2020 · L. Rousset, N. Haddad, et al. · Annales de Dermatologie et de Vénéréologie
Works count: 11
Citation count: 171
H-index: 4
I10-index: 4
Year
Topic
Type